Atlas FDA

EXCLUDER BIFURCATED ENDOPROSTHESIS

FDA premarket approval P020004/S011 · decided 2005-09-28

Approval details

PMA number
P020004
Supplement
S011
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
EXCLUDER BIFURCATED ENDOPROSTHESIS
Generic name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Applicant
W. L. Gore & Associates, Inc.
Date received
2005-05-06
Decision date
2005-09-28
Days to decision
145 days
Decision code
APPR
Product code
MIH
Advisory committee
Cardiovascular
Expedited review
No
Location
Phonix, AZ
Statement
APPROVAL FOR THE ADDITION OF A SHORTER (12 CM) TRUNK/IPSILATERAL COMPONENT TO THE GORE EXCLUDER? BIFURCATED ENDOPROSTHESIS PRODUCT LINE.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
GORE® Tri-Lobe Balloon Catheter (K250410)W. L. Gore & Associates, Inc.2025-06-02
GORE® PROPATEN® Vascular Graft (K240083)W. L. Gore & Associates, Inc.2024-03-01
GORE® PROPATEN® Vascular Graft (K232312)W. L. Gore & Associates, Inc.2024-01-09
GORE® ACUSEAL Vascular Graft (K233551)W. L. Gore & Associates, Inc.2023-12-19
GORE® ACUSEAL Vascular Graft (K231505)W. L. Gore & Associates, Inc.2023-06-23
GORE BIO-A Tissue Reinforcement (K191773)W. L. Gore & Associates, Inc.2019-07-31
GORE SEAMGUARD Bioabsorbable Staple Line Reinforcement (K181940)W. L. Gore & Associates, Inc.2018-08-17
GORE ENFORM Biomaterial (K173333)W. L. Gore & Associates, Inc.2018-04-05